Roy Castle Lung Cancer Foundation has been certified as a provider of high quality health and social care information by The Information Standard scheme.
The Information Standard is a quality assurance standard, supported by NHS England, that has been established to improve the quality of health and social care information. The standard has been designed to test whether organisations have methods and systems to ensure that the information produced for the public is accurate, impartial, balanced, evidence-based and well written. It also ensures that people affected by lung cancer are at the heart of all the information produced.
We met the scheme criteria of producing safe and reliable health and social care information and can now display the quality mark on our health information materials and our website illustrating to the public that the information can be trusted.
Roy Castle Lung Cancer Foundation are responsible for the accuracy of the information on this website. Neither NHS England or The Information Standard will have any responsibility for this information.
ISD provides health information, health intelligence, statistical services and advice that support the NHS in progressing quality improvement in health and care and facilitates robust planning and decision making. For more info visit
National Lung Cancer Audit (LUCADA)
The National Lung Cancer Audit looks at the care delivered during referral, diagnosis, treatment and outcomes for people diagnosed with lung cancer and mesothelioma. For more info visit.
National Awareness and Early Diagnosis Initiative (NAEDI)
The role of National Awareness and Early Diagnosis Initiative is to coordinate and provide support to activities and research that promote the earlier diagnosis of cancer. For more info visit.
National Institute for Health and Care Excellence (NICE)
It is responsible for collecting and publishing statistics related to the economy, population and society at national, regional and local levels. It also provides cancer statistics for cancer incidence and mortality. For more info visit.
Scottish Medicines Consortium (SMC)
Its purpose is to accept for use those newly licensed drugs that clearly represent good value for money to NHS Scotland. SMC analyses information supplied by the drug manufacturer on the health benefits of the drug and justification of its price. For more info visit.
The Scottish Intercollegiate Guidelines Network (SIGN)